Lisa Bodell: Change Is a Choice
In this article, Lisa Bodell challenges the way we typically think about change. Rather than viewing it as a dramatic, all-or-nothing leap, she reframes change…
Thought Leader: Lisa Bodell
How The Feds Discourage Prescription Drug Competition
July 1, 2015
Source: Link
By Scott Gottlieb (original source Forbes)
“There’s a growing refrain among those who pay for healthcare services that they want new products to deliver more value. When it comes to prescription drugs, this is usually interpreted to mean medicines that provide more benefit, at lower costs per increment of clinical advantage. Drugs that deliver more bang for the buck.
But pharmaceutical competition usually turns on claims of absolute efficacy rather than the relative and comparative merits of a medicine. There is one obvious reason.
Drug companies can rarely make claims around the value of their medicines.”
Click here to read more
Relevant and recent posts
Sara Fischer on Meta’s AI Infrastructure Push
In an article by Sara Fischer, Meta CEO Mark Zuckerberg outlines the company’s launch of Meta Compute, a new top-level initiative focused on scaling AI…
Thought Leader: Sara Fischer
Ian Bremmer: What’s Next for Venezuela
After the US captures Nicolás Maduro, is Venezuela headed for stability, or chaos? Ian Bremmer talks to Senator Ruben Gallego and Frank Fukuyama about what…
Thought Leader: Ian Bremmer
Recent posts
Lisa Bodell: Change Is a Choice
Thought Leader: Lisa Bodell
Sara Fischer on Meta’s AI Infrastructure Push
Thought Leader: Sara Fischer
Ian Bremmer: What’s Next for Venezuela
Thought Leader: Ian Bremmer